Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study

Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare the risk of stroke/systemic embolism (S/SE) and major bleeding (MB) between patients treated with reduced-dose NOACs and those t...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Sola, Kim, Young-Hoon, Lee, Myung-Yong, Bang, Oh Young, Jang, Sung-Won, Han, Seongwook, Park, Yoo-Jung, Kang, Seongsik, On, Young Keun, Suh, Hae Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432037/
https://www.ncbi.nlm.nih.gov/pubmed/34501364
http://dx.doi.org/10.3390/jcm10173918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432037/
https://www.ncbi.nlm.nih.gov/pubmed/34501364
http://dx.doi.org/10.3390/jcm10173918

Ejemplares similares